Patents Assigned to Illumina Cambridge Limited
  • Patent number: 12264361
    Abstract: An image sensor structure includes an image layer having an array of light detectors disposed therein. A device stack is disposed over the image layer. An array of light guides is disposed in the device stack. Each light guide is associated with a light detector. An array of nanowells is disposed over the device stack. Each nanowell is associated with a first light guide of the array of light guides. A first primer set is disposed throughout a first well region of each nanowell. A second primer set is disposed throughout a second well region of each nanowell. The second well region is adjacent the first well region. The first and second primer sets are operable to attach a forward strand cluster of forward polynucleotide strands in the first well region and a reverse strand cluster of reverse polynucleotide strands in the second well region.
    Type: Grant
    Filed: December 9, 2021
    Date of Patent: April 1, 2025
    Assignees: Illumina, Inc., Illumina Cambridge Limited
    Inventors: Lewis Kraft, Craig Lee Hetherington, Craig M. Ciesla, Michael Burek, Jeffrey Fisher, Jason Betley
  • Patent number: 12247254
    Abstract: The present invention is concerned with compositions and methods for improving the rate of correct sample identification in indexed nucleic acid library preparations for multiplex next generation sequencing by modifying or blocking 5? and 3? ends of pooled indexed polynucleotides from multiple samples, with an optional exonuclease treatment, prior to amplification and sequencing.
    Type: Grant
    Filed: February 22, 2021
    Date of Patent: March 11, 2025
    Assignees: Illumina, Inc., Illumina Cambridge Limited
    Inventors: Eric Hans Vermaas, Mahdieh Khosroheidari, Claire Bevis-Mott
  • Publication number: 20250059521
    Abstract: Presented herein are altered polymerase enzymes for improved incorporation of nucleotides and nucleotide analogues, in particular altered polymerases that maintain high fidelity under reduced incorporation times, as well as methods and kits using the same.
    Type: Application
    Filed: September 4, 2024
    Publication date: February 20, 2025
    Applicants: ILLUMINA, INC., ILLUMINA CAMBRIDGE LIMITED, ILLUMINA SINGAPORE PTE. LTD.
    Inventors: Kay Klausing, Hamed Tabatabaei Ghomi, Misha Golynskiy, Saurabh Nirantar, Seth McDonald, Sergio Peisajovich
  • Publication number: 20250059589
    Abstract: Presented herein are methods and compositions for targeted amplification of DNA and sample identification. The methods are particularly useful in validation and quality control of samples and to confirm that WGS sequence data is properly paired with a patient sample prior to delivering sequence data to a physician or to a patient.
    Type: Application
    Filed: October 24, 2024
    Publication date: February 20, 2025
    Applicant: ILLUMINA CAMBRIDGE LIMITED
    Inventor: Louise FRASER
  • Patent number: 12227802
    Abstract: Embodiments of the present disclosure relate to nucleotide molecules with a 3? AOM blocking group. Also provided herein are methods to prepare such nucleotide molecules, and the uses of fully functionalized nucleotides containing the 3?-OH blocking group for sequencing applications.
    Type: Grant
    Filed: October 17, 2023
    Date of Patent: February 18, 2025
    Assignee: Illumina Cambridge Limited
    Inventors: Antoine Francais, Elena Cressina, Adam Culley, Angelica Mariani, Xiaolin Wu, Xiaohai Liu
  • Patent number: 12217832
    Abstract: The technology disclosed directly operates on sequencing data and derives its own feature filters. It processes a plurality of aligned reads that span a target base position. It combines elegant encoding of the reads with a lightweight analysis to produce good recall and precision using lightweight hardware. For instance, one million training examples of target base variant sites with 50 to 100 reads each can be trained on a single GPU card in less than 10 hours with good recall and precision. A single GPU card is desirable because it a computer with a single GPU is inexpensive, almost universally within reach for users looking at genetic data. It is readily available on could-based platforms.
    Type: Grant
    Filed: May 9, 2023
    Date of Patent: February 4, 2025
    Assignees: Illumina, Inc., Illumina Cambridge Limited
    Inventors: Ole Schulz-Trieglaff, Anthony James Cox, Kai-How Farh
  • Patent number: 12195796
    Abstract: Embodiments of the present disclosure relate to cyclooctatetraene containing dyes and their uses as fluorescent labels. Also provided are composition containing cyclooctatetraene. The dyes and compositions may be used in various biological applications, such as nucleic acid sequencing.
    Type: Grant
    Filed: May 2, 2023
    Date of Patent: January 14, 2025
    Assignee: Illumina Cambridge Limited
    Inventors: Xiaolin Wu, Xiaohai Liu, Nikolai Nikolaevich Romanov, Antoine Francais, Patrick McCauley, Michael Callingham, Carole Anastasi
  • Patent number: 12188078
    Abstract: Presented are methods and compositions for preparing samples for amplification and sequencing. Particular embodiments relate to methods of preparing nucleic acid containing cellular samples for library amplification, wherein the methods include lysing cells of the sample to form a lysate, amplifying the nucleic acids from the lysed samples, wherein there is no purification of the nucleic acids from the lysate prior to the amplification, wherein amplifying comprises tagmentation, and sequencing the nucleic acids, wherein the sample is a blood sample or a formalin-fixed paraffin-embedded (FFPE) sample.
    Type: Grant
    Filed: September 15, 2021
    Date of Patent: January 7, 2025
    Assignee: Illumina Cambridge Limited
    Inventors: Louise Fraser, Paula Kokko-Gonzales, Andrew Slatter
  • Publication number: 20240425632
    Abstract: Some examples herein provide a method that includes reacting an unsaturated cyclic dione with an indole or indazole to form a first adduct. One of a substrate and a functional group is coupled to the unsaturated cyclic dione, and the other of the substrate and the functional group is coupled to the indole or indazole. Forming the first adduct couples the functional group to the substrate. Some examples herein provide a composition that includes a substate, a functional group, and an adduct coupling the functional group to the substrate. The adduct may be a product of a reaction between an unsaturated cyclic dione and an indole or indazole.
    Type: Application
    Filed: July 3, 2024
    Publication date: December 26, 2024
    Applicants: ILLUMINA, INC., ILLUMINA CAMBRIDGE LIMITED
    Inventors: Randall Smith, Wayne George, Andrew Brown
  • Patent number: 12157910
    Abstract: Presented herein are methods and compositions for targeted amplification of DNA and sample identification. The methods are particularly useful in validation and quality control of samples and to confirm that WGS sequence data is properly paired with a patient sample prior to delivering sequence data to a physician or to a patient.
    Type: Grant
    Filed: July 5, 2016
    Date of Patent: December 3, 2024
    Assignee: ILLUMINA CAMBRIDGE LIMITED
    Inventor: Louise Fraser
  • Patent number: 12157252
    Abstract: An imprinting apparatus includes a silicon master having a plurality of nanofeatures defined therein. An anti-stick layer coats the silicon master, the anti-stick layer including a molecule having a cyclosiloxane with at least one silane functional group. A method includes forming a master template by: depositing a formulation on a silicon master including a plurality of nanofeatures defined therein, the formulation including a solvent and a molecule having a cyclosiloxane with at least one silane functional group; and curing the formulation, thereby forming an anti-stick layer on the silicon master, the anti-stick layer including the molecule. The method further includes depositing a silicon-based working stamp material on the anti-stick layer of the master template; curing the silicon-based working stamp material to form a working stamp including a negative replica of the plurality of nanofeatures; and releasing the working stamp from the master template.
    Type: Grant
    Filed: December 2, 2021
    Date of Patent: December 3, 2024
    Assignees: Illumina, Inc., Illumina Cambridge Limited
    Inventors: Alexandre Richez, Andrew A. Brown, Julia Morrison, Wayne N. George, Timothy J. Merkel, Audrey Rose Zak
  • Patent number: 12152237
    Abstract: An example of a functionalized plasmonic nanostructure includes a plasmonic nanostructure core; a polymeric hydrogel attached to the plasmonic nanostructure core, the polymeric hydrogel having a thickness ranging from about 10 nm to about 200 nm; and a plurality of primers attached to side chains or arms of the polymeric hydrogel, wherein at least some of the plurality of primers are attached to the polymeric hydrogel at different distances from the plasmonic nanostructure core.
    Type: Grant
    Filed: November 12, 2021
    Date of Patent: November 26, 2024
    Assignees: Illumina, Inc., Illumina Cambridge Limited
    Inventors: Gianluca Andrea Artioli, Mathieu Lessard-Viger, Brian D. Mather, Xavier von Hatten
  • Patent number: 12123056
    Abstract: Presented herein are methods and compositions for concatenating template strands during the bridge amplification process. The methods are useful for surface amplification at improved densities. The methods and compositions provided herein enable creation of clusters that are brighter, but at the same densities as currently achieved using standard cluster amplification.
    Type: Grant
    Filed: January 20, 2021
    Date of Patent: October 22, 2024
    Assignee: ILLUMINA CAMBRIDGE LIMITED
    Inventor: Jonathan Mark Boutell
  • Patent number: 12110546
    Abstract: The present application relates to tertiary amine substituted coumarin derivatives and their uses as fluorescent labels. These compounds may be used as fluorescent labels for nucleotides in nucleic acid sequencing applications.
    Type: Grant
    Filed: February 28, 2020
    Date of Patent: October 8, 2024
    Assignee: Illumina Cambridge Limited
    Inventors: Nikolai Nikolaevich Romanov, Patrick McCauley, Niall Hynes
  • Patent number: 12104182
    Abstract: Presented herein are altered polymerase enzymes for improved incorporation of nucleotides and nucleotide analogues, in particular altered polymerases that maintain high fidelity under reduced incorporation times, as well as methods and kits using the same.
    Type: Grant
    Filed: March 13, 2023
    Date of Patent: October 1, 2024
    Assignees: ILLUMINA, INC., ILLUMINA CAMBRIDGE LIMITED, ILLUMINA SINGAPORE PTE. LTD.
    Inventors: Kay Klausing, Hamed Tabatabaei Ghomi, Misha Golynskiy, Saurabh Nirantar, Seth McDonald, Sergio Peisajovich
  • Patent number: 12091713
    Abstract: An imaging system includes: a sample container including a flowcell that includes a plurality of attachment elements at a plurality of sample locations, wherein a single DNA template molecule is attached to each of the attachment elements, and further wherein an average distance between adjacent attachment elements is less than Abbe's limit; and an imager positioned to image photo-switching occurring at the plurality of attachment elements by capturing on and off events in a plurality of color channels at the same time as the on and off events are occurring for the attached molecules when a stochastic photo-switching chemistry is applied to all of the attached molecules at the same time causing the attached molecules to fluoresce in the on and off events in up to four different colors.
    Type: Grant
    Filed: August 5, 2021
    Date of Patent: September 17, 2024
    Assignees: ILLUMINA CAMBRIDGE LIMITED, ILLUMINA, INC.
    Inventors: Gary Mark Skinner, Geraint Wyn Evans, Stanley S. Hong
  • Publication number: 20240301401
    Abstract: Presented are methods and compositions for using immobilized transposase and a transposon end for generating an immobilized library of 5?-tagged double-stranded target DNA on a surface. The methods are useful for generating 5?- and 3?-tagged DNA fragments for use in a variety of processes, including massively parallel DNA sequencing.
    Type: Application
    Filed: March 27, 2024
    Publication date: September 12, 2024
    Applicant: Illumina Cambridge Limited
    Inventors: Niall Anthony Gormley, Geoffrey Paul Smith
  • Publication number: 20240287504
    Abstract: Genomic library preparation using Cas-gRNA RNPs, and targeted epigenetic assays, are provided herein. Some compositions include, from a first species, substantially only single-stranded polynucleotides; from a second species, substantially only double-stranded polynucleotides; and amplification primers ligated to ends of the second double-stranded polynucleotides and substantially not ligated to any ends of the first double-stranded polynucleotides. Some compositions include first and second molecules of a target polynucleotide having a sequence, the first molecule having a first end at a first subsequence, the second molecule having a first end at a second subsequence, wherein the first subsequence only partially overlaps with the second subsequence. Some examples provide a composition that includes a target polynucleotide and a first fusion protein including a Cas-gRNA RNP coupled to a transposase having an amplification adapter coupled thereto.
    Type: Application
    Filed: March 8, 2022
    Publication date: August 29, 2024
    Applicants: Illumina, Inc., Illumina Cambridge Limited
    Inventors: Andrew Kennedy, Sarah Shultzaberger, Emma Bell, Oliver Miller, Kim Schneider, Esther Musgrave-Brown, Niall Gormley, Andrew Slatter, Feng Chen
  • Patent number: 12071711
    Abstract: The present invention relates to a method for preparing a library of template polynucleotides and use thereof in methods of solid-phase nucleic acid amplification. More specifically, the invention relates to a method for preparing a library of template polynucleotides that have common sequences at their 5? ends and at their 3? ends.
    Type: Grant
    Filed: September 9, 2021
    Date of Patent: August 27, 2024
    Assignee: Illumina Cambridge Limited
    Inventors: Niall Anthony Gormley, Geoffrey Paul Smith, David Bentley, Roberto Rigatti, Shujun Luo
  • Patent number: 12071662
    Abstract: The present disclosure relates to new nucleotide and oligonucleotide compounds and their use in nucleic acid sequencing applications.
    Type: Grant
    Filed: May 5, 2023
    Date of Patent: August 27, 2024
    Assignee: Illumina Cambridge Limited
    Inventors: Elena Cressina, Antoine Francais, Xiaohai Liu